Sabatier R - Search Results

1

Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer.

Sabatier R, Martin J, Vicier C, Guérin M, Monneur A, Provansal M, Tassy L, Tarpin C, Extra JM, Viret F, Goncalves A. Sabatier R, et al. J Clin Med. 2021 Mar 18;10(6):1272. doi: 10.3390/jcm10061272. J Clin Med. 2021. PMID: 33803894 Free PMC article.

2

A gene expression signature identifies two prognostic subgroups of basal breast cancer.

Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, Mamessier E, Tallet A, Chabannon C, Extra JM, Jacquemier J, Viens P, Birnbaum D, Bertucci F. Sabatier R, et al. Breast Cancer Res Treat. 2011 Apr;126(2):407-20. doi: 10.1007/s10549-010-0897-9. Epub 2010 May 21. Breast Cancer Res Treat. 2011. PMID: 20490655 Free article.

3

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.

Gonçalves A, Finetti P, Sabatier R, Gilabert M, Adelaide J, Borg JP, Chaffanet M, Viens P, Birnbaum D, Bertucci F. Gonçalves A, et al. Among authors: sabatier r. Breast Cancer Res Treat. 2011 May;127(1):273-81. doi: 10.1007/s10549-010-1199-y. Epub 2010 Nov 11. Breast Cancer Res Treat. 2011. PMID: 21069454

4

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

Sabatier R, Jacquemier J, Bertucci F, Esterni B, Finetti P, Azario F, Birnbaum D, Viens P, Gonçalves A, Extra JM. Sabatier R, et al. Eur J Cancer. 2011 Jul;47(10):1537-45. doi: 10.1016/j.ejca.2011.02.002. Epub 2011 Mar 8. Eur J Cancer. 2011. PMID: 21392964

5

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

Sabatier R, Gonçalves A, Bertucci F, Capiello MA, Rousseau F, Lambaudie E, Chabannon C, Viens P, Extra JM. Sabatier R, et al. J Exp Clin Cancer Res. 2012 Oct 16;31(1):87. doi: 10.1186/1756-9966-31-87. J Exp Clin Cancer Res. 2012. PMID: 23072336 Free PMC article.

6

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

Gonçalves A, Sabatier R, Charafe-Jauffret E, Gilabert M, Provansal M, Tarpin C, Extra JM, Viens P, Bertucci F. Gonçalves A, et al. Among authors: sabatier r. Bull Cancer. 2013 May;100(5):453-64. doi: 10.1684/bdc.2013.1740. Bull Cancer. 2013. PMID: 23695030 Review. French.

7

Personalized medicine: present and future of breast cancer management.

Sabatier R, Gonçalves A, Bertucci F. Sabatier R, et al. Crit Rev Oncol Hematol. 2014 Sep;91(3):223-33. doi: 10.1016/j.critrevonc.2014.03.002. Epub 2014 Mar 26. Crit Rev Oncol Hematol. 2014. PMID: 24725667 Review.

8

[Pertuzumab (Perjeta®) approval in HER2-positive metastatic breast cancers].

Sabatier R, Gonçalves A. Sabatier R, et al. Bull Cancer. 2014 Jul-Aug;101(7-8):765-71. doi: 10.1684/bdc.2014.1940. Bull Cancer. 2014. PMID: 25091659 French.

9

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.

Sabatier R, Calderon B Jr, Lambaudie E, Chereau E, Provansal M, Cappiello MA, Viens P, Rousseau F. Sabatier R, et al. Int J Gynecol Cancer. 2015 Jun;25(5):815-22. doi: 10.1097/IGC.0000000000000418. Int J Gynecol Cancer. 2015. PMID: 25768081

10

[Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers].

Guerin M, Sabatier R, Gonçalves A. Guerin M, et al. Among authors: sabatier r. Bull Cancer. 2015 Apr;102(4):390-7. doi: 10.1016/j.bulcan.2015.02.007. Epub 2015 Mar 16. Bull Cancer. 2015. PMID: 25790739 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page